<< New Gout Drug Krystexxa Exceeds Target

Warning for Arthritis Patients Who Take NSAIDs >>

Anti-Gout Drug May Decrease Risk of Colon Cancer

September 6, 2011 by Lynn.

colorectal_cancer_s1_illustartion
colorectal_cancer_s1_illustartion
Allopurinol, a relatively inexpensive gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, or polyps, according to two separate studies. Most colorectal cancer develops from adenomatous polyps.

A large study in Israel showed that patients using allopurinol for gout had a lower risk of colorectal cancer than a control group not taking allopurinol. A second study in Italy appeared to confirm that the gout medicine protects against colon carcinogenesis. To read the full article on ScienceDaily, CLICK HERE.<


Filed under: Cancer, Gout Medications.

Tags: anti-gout drug, gout medication, allopurinol for gout, gout medicine, allopurinol, colchicine.ca, colchicine.


Leave your comment:

Name (required, limit 30 characters):
Email (required, will not be published):
Your Comment:
Veri Code (not case-sensitive):
    
Most Recent Posts
Category
Archives